Delivery Order SPE2DB24D2100-SPE2DB24FBDLD

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.24 firm fixed-price contract is for the supply of methylergonovine 0.2 mg/ml ampompoules, a prescription medication. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,120.10 firm-fixed-price contract is for the delivery of 4,568,193,879 units of the medication methylergonovine 0.2 mg tablets. The contract has a performance period through May 12, 2025 and was awarded on May 9, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylergonovine 0.2 mg/ml injections. The contract has a total ceiling value of $1,794.96 and is a firm fixed-price delivery order. It does not have a set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,196.64 fixed-price contract is for the supply of 4565545266 - Methylergonovine 0.2 mg/ml vials. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds significant indefinite delivery contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
This federal contract award, valued at $6,322.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,563,416,314 units of the drug Methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of January 24, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,550 units of the medication Methylergonovine 0.2 mg Tablet. The firm-fixed-price contract, valued at $4,134.76, has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through...
This federal contract award, valued at $1,209.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg/ml Amp ML, a medication used to treat postpartum bleeding. The contract was awarded as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFGDV, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the procurement of 4566307162 - METHYLERGONOVINE 0.2 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $2,681.56 and a completion date of November 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDLD
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565735670 - Methylergonovine 0.2 mg/mL vials. The $2,970.20 firm-fixed-price contract has a completion date of September 10, 2024. While this delivery order is not designated as a set-aside, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract facilitates the efficient procurement of critical pharmaceutical products and supplies by government agencies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/9/24, 1:55 PM